This study using in silico approach sought to identify potential plant antimicrobial peptides as selective inhibitors of Slc2a4 in order to develop a more potent anti-cancer therapy with high efficacy, excellent tolerability, and few transient side effects. The gene discussed is SLC2A4; the disease is cancer.